Loading...
Loading...
By Sofía Garduño - Thu, 12/11/2025 - 18:36
This week, Pfizer formalizes a new GLP-1 partnership, PAHO strengthens HIV elimination efforts, and Mexico prepares to vote on e-cigarette oversight
https://mexicobusiness.news/tag/pfizer
More Health
By Sofía Garduño - Thu, 06/19/2025 - 09:46
Pfizer joins forces with the Pan American Health Organization (PAHO) to strengthen regional vaccine capacity throughout the region.
By MBN Staff - Mon, 01/20/2025 - 15:43
PAHO, Argentina’s government, Pfizer, and Sinergium Biotech collaborate to produce and distribute the PCV20 vaccine regionally.
By MBN Staff - Mon, 12/23/2024 - 13:39
Pfizer's BRAFTOVI, combined with cetuximab and mFOLFOX6, is FDA-approved for treating metastatic colorectal cancer with a BRAF V600E mutation.
By Enrique Culebro - Tue, 12/17/2024 - 14:00
Digital study looks at the digital habits of physicians in Mexico and how they are using technology in their practices. Enrique Culebro explains.
By Eugenio MarÍn - Wed, 12/11/2024 - 08:00
ESG principles can contribute to the sustainability of organizations by focusing on identifying the areas of greatest impact, writes Eugenio Marin.
By Eugenio MarÍn - Fri, 11/29/2024 - 12:00
ESG criteria are being adopted by companies that, although not public, see value in the information generated by these criteria, writes Eugenio Marin.
By MBN Staff - Thu, 10/24/2024 - 09:34
Pfizer’s RSV vaccine, received FDA approval to protect high-risk adults aged 18 to 59.
By MBN Staff - Wed, 10/16/2024 - 10:51
The FDA approves Hympavzi, a once-weekly injection for hemophilia A and B, improving treatment and patient quality of life.
By MBN Staff - Tue, 09/24/2024 - 11:54
The Omicron KP.2 COVID-19 vaccine being developed by Pfizer and BioNTech could be used to immunize individuals aged six months and older.
